Keyphrases
Patients with COVID-19
100%
Low-dose Hydrocortisone
100%
Severe Hypoxia
100%
Randomized Placebo-controlled Trial
100%
Coronavirus Disease (COVID)
100%
COVID-19
75%
Hydrocortisone
75%
Corticosteroids
50%
Placebo
50%
Number of Days
50%
Days Alive without Life Support
50%
Placebo-controlled
25%
External Evidence
25%
Hospital Discharge
25%
Placebo Groups
25%
Serious Adverse Reaction
25%
Clinical Database
25%
Clinical Trials
25%
Severe COVID-19
25%
Drug Regulation
25%
Adjusted Means
25%
European Union
25%
Supplemental Oxygen
25%
Patient-centered Outcomes
25%
Mechanical Ventilation
25%
Critically Ill Patients
25%
Medicine and Dentistry
Low Drug Dose
100%
COVID-19
100%
Hydrocortisone
100%
Placebo
100%
Hypoxia
100%
Clinical Trial
33%
Artificial Respiration
16%
Adverse Event
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hydrocortisone
100%
Placebo
100%
Hypoxia
100%
Clinical Trial
40%
Adverse Event
20%
